Molecular Therapy: Methods & Clinical Development (Mar 2024)

Nonviral delivery of nCas9 for “safe harbor” integration to treat MPS IVA

Li Ou

Affiliations

Li Ou: Avirmax Biopharma, Inc., Hayward, CA, USA; Corresponding author: Li Ou, Avirmax Biopharma, Inc., Hayward, CA, USA.

Journal volume & issue: Vol. 32, no. 1
p. 101178

Abstract

No abstracts available.

Published in Molecular Therapy: Methods & Clinical Development

ISSN: 2329-0501 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Science: Biology (General): Genetics; Science: Biology (General): Cytology
Website: http://www.cell.com/molecular-therapy-family/methods/latest-content

About the journal